Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
Filings by filing date
News
Biz Brief
Sector: Consumer Non-Cyclicals | Industry: Food Processing |
Company Contact | |
Address: | 1600 - 609 Granville St VANCOUVER BC V7Y 1C3 |
Tel: | N/A |
Website: | https://neutrisci.com |
IR: | See website |
Key People | ||
Glen Rehman President, Chief Executive Officer, Director | Robert Chisholm Chief Financial Officer |
Business Overview |
NeutriSci International Inc. (NeutriSci) is a Canada-based company, which specializes in the development, formulation, and production of products for its business-to-business (B2B) partners around the globe. The Company is focused on the market development for its nutraceutical products. Its products utilize patented form of Pterostilbene called pTeroPure. pTeroPure Pterostilbene is a form of all-trans Pterostilbene that is found naturally in blueberries and is manufactured for NeutriSci by ChromaDex Corp. (ChromaDex) in the United States. NeutriSci's neuenergy product is an energy tab designed to deliver enhanced focus and mental clarity with no sugar, no calories and no crash that is associated with energy products. It has developed proprietary IP and technology (NeutriSci IP) that creates an efficient method of bilingual absorption of nutraceuticals into the bloodstream. NeutriSci's IP can be applied to many different categories in the beverage, food, and nutraceutical space. |
Financial Overview |
For the nine months ended 30 September 2023, NeutriSci International Inc revenues decreased 98% to C$9K. Net loss decreased 39% to C$335K. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Salaries and benefits decrease of 97% to C$5K (expense), Foreign exchange decrease from C$23K (expense) to C$0K. |
Reporting Currency: | Canadian Dollars |
Enterprise value: | $0.90M as of Sep 30, 2023 |
Annual revenue (TTM): | $0.06M as of Sep 30, 2023 |
EBITDA (TTM): | -$0.46M as of Sep 30, 2023 |
Net annual income (TTM): | -$0.55M as of Sep 30, 2023 |
Free cash flow (TTM): | -$0.26M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | $0.21M as of Sep 30, 2023 |
Shares outstanding: | 178,424,267 as of Sep 30, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |